Hemodilution on cardiopulmonary bypass as a determinant of early postoperative hyperlactatemia

Marco Ranucci, Giovanni Carboni, Mauro Cotza, Paolo Bianchi, Umberto Di Dedda, Tommaso Aloisio

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Objective: The nadir hematocrit (HCT) on cardiopulmonary bypass (CPB) is a recognized independent risk factor for major morbidity and mortality in cardiac surgery. The main interpretation is that low levels of HCT on CPB result in a poor oxygen delivery and dysoxia of end organs. Hyperlactatemia (HL) is a marker of dysoxic metabolism, and is associated with bad outcomes in cardiac surgery. This study explores the relationship between nadir HCT on CPB and early postoperative HL. Design: Retrospective study on 3,851 consecutive patients. Measurements and Main Results: Nadir HCT on CPB and other potential confounders were explored for association with blood lactate levels at the arrival in the Intensive Care Unit (ICU), and with the presence of moderate (2.1 - 6.0 mMol/L) or severe (> 6.0 mMol/L) HL. Nadir HCT on CPB demonstrated a significant negative association with blood lactate levels at the arrival in the ICU. After adjustment for the other confounders, the nadir HCT on CPB remained independently associated with moderate (odds ratio 0.96, 95% confidence interval 0.94-0.99) and severe HL (odds ratio 0.91, 95% confidence interval 0.86-0.97). Moderate and severe HL were significantly associated with increased morbidity and mortality. Conclusions: Hemodilution on CPB is an independent determinant of HL. This association, more evident for severe HL, strengthens the hypothesis that a poor oxygen delivery on CPB with consequent organ ischemia is the mechanism leading to hemodilution-associated bad outcomes.

Original languageEnglish
Article numbere0126939
JournalPLoS One
Volume10
Issue number5
DOIs
Publication statusPublished - May 18 2015

Fingerprint

Intensive care units
Hemodilution
Cardiopulmonary Bypass
Surgery
hematocrit
Lactic Acid
Blood
Hematocrit
Oxygen
Metabolism
odds ratio
lactates
morbidity
confidence interval
surgery
Thoracic Surgery
Intensive Care Units
oxygen
Odds Ratio
blood

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Hemodilution on cardiopulmonary bypass as a determinant of early postoperative hyperlactatemia. / Ranucci, Marco; Carboni, Giovanni; Cotza, Mauro; Bianchi, Paolo; Di Dedda, Umberto; Aloisio, Tommaso.

In: PLoS One, Vol. 10, No. 5, e0126939, 18.05.2015.

Research output: Contribution to journalArticle

Ranucci, Marco ; Carboni, Giovanni ; Cotza, Mauro ; Bianchi, Paolo ; Di Dedda, Umberto ; Aloisio, Tommaso. / Hemodilution on cardiopulmonary bypass as a determinant of early postoperative hyperlactatemia. In: PLoS One. 2015 ; Vol. 10, No. 5.
@article{cff6d0b9b9894017ac93a779ad2a3028,
title = "Hemodilution on cardiopulmonary bypass as a determinant of early postoperative hyperlactatemia",
abstract = "Objective: The nadir hematocrit (HCT) on cardiopulmonary bypass (CPB) is a recognized independent risk factor for major morbidity and mortality in cardiac surgery. The main interpretation is that low levels of HCT on CPB result in a poor oxygen delivery and dysoxia of end organs. Hyperlactatemia (HL) is a marker of dysoxic metabolism, and is associated with bad outcomes in cardiac surgery. This study explores the relationship between nadir HCT on CPB and early postoperative HL. Design: Retrospective study on 3,851 consecutive patients. Measurements and Main Results: Nadir HCT on CPB and other potential confounders were explored for association with blood lactate levels at the arrival in the Intensive Care Unit (ICU), and with the presence of moderate (2.1 - 6.0 mMol/L) or severe (> 6.0 mMol/L) HL. Nadir HCT on CPB demonstrated a significant negative association with blood lactate levels at the arrival in the ICU. After adjustment for the other confounders, the nadir HCT on CPB remained independently associated with moderate (odds ratio 0.96, 95{\%} confidence interval 0.94-0.99) and severe HL (odds ratio 0.91, 95{\%} confidence interval 0.86-0.97). Moderate and severe HL were significantly associated with increased morbidity and mortality. Conclusions: Hemodilution on CPB is an independent determinant of HL. This association, more evident for severe HL, strengthens the hypothesis that a poor oxygen delivery on CPB with consequent organ ischemia is the mechanism leading to hemodilution-associated bad outcomes.",
author = "Marco Ranucci and Giovanni Carboni and Mauro Cotza and Paolo Bianchi and {Di Dedda}, Umberto and Tommaso Aloisio",
year = "2015",
month = "5",
day = "18",
doi = "10.1371/journal.pone.0126939",
language = "English",
volume = "10",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "5",

}

TY - JOUR

T1 - Hemodilution on cardiopulmonary bypass as a determinant of early postoperative hyperlactatemia

AU - Ranucci, Marco

AU - Carboni, Giovanni

AU - Cotza, Mauro

AU - Bianchi, Paolo

AU - Di Dedda, Umberto

AU - Aloisio, Tommaso

PY - 2015/5/18

Y1 - 2015/5/18

N2 - Objective: The nadir hematocrit (HCT) on cardiopulmonary bypass (CPB) is a recognized independent risk factor for major morbidity and mortality in cardiac surgery. The main interpretation is that low levels of HCT on CPB result in a poor oxygen delivery and dysoxia of end organs. Hyperlactatemia (HL) is a marker of dysoxic metabolism, and is associated with bad outcomes in cardiac surgery. This study explores the relationship between nadir HCT on CPB and early postoperative HL. Design: Retrospective study on 3,851 consecutive patients. Measurements and Main Results: Nadir HCT on CPB and other potential confounders were explored for association with blood lactate levels at the arrival in the Intensive Care Unit (ICU), and with the presence of moderate (2.1 - 6.0 mMol/L) or severe (> 6.0 mMol/L) HL. Nadir HCT on CPB demonstrated a significant negative association with blood lactate levels at the arrival in the ICU. After adjustment for the other confounders, the nadir HCT on CPB remained independently associated with moderate (odds ratio 0.96, 95% confidence interval 0.94-0.99) and severe HL (odds ratio 0.91, 95% confidence interval 0.86-0.97). Moderate and severe HL were significantly associated with increased morbidity and mortality. Conclusions: Hemodilution on CPB is an independent determinant of HL. This association, more evident for severe HL, strengthens the hypothesis that a poor oxygen delivery on CPB with consequent organ ischemia is the mechanism leading to hemodilution-associated bad outcomes.

AB - Objective: The nadir hematocrit (HCT) on cardiopulmonary bypass (CPB) is a recognized independent risk factor for major morbidity and mortality in cardiac surgery. The main interpretation is that low levels of HCT on CPB result in a poor oxygen delivery and dysoxia of end organs. Hyperlactatemia (HL) is a marker of dysoxic metabolism, and is associated with bad outcomes in cardiac surgery. This study explores the relationship between nadir HCT on CPB and early postoperative HL. Design: Retrospective study on 3,851 consecutive patients. Measurements and Main Results: Nadir HCT on CPB and other potential confounders were explored for association with blood lactate levels at the arrival in the Intensive Care Unit (ICU), and with the presence of moderate (2.1 - 6.0 mMol/L) or severe (> 6.0 mMol/L) HL. Nadir HCT on CPB demonstrated a significant negative association with blood lactate levels at the arrival in the ICU. After adjustment for the other confounders, the nadir HCT on CPB remained independently associated with moderate (odds ratio 0.96, 95% confidence interval 0.94-0.99) and severe HL (odds ratio 0.91, 95% confidence interval 0.86-0.97). Moderate and severe HL were significantly associated with increased morbidity and mortality. Conclusions: Hemodilution on CPB is an independent determinant of HL. This association, more evident for severe HL, strengthens the hypothesis that a poor oxygen delivery on CPB with consequent organ ischemia is the mechanism leading to hemodilution-associated bad outcomes.

UR - http://www.scopus.com/inward/record.url?scp=84930662751&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84930662751&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0126939

DO - 10.1371/journal.pone.0126939

M3 - Article

VL - 10

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 5

M1 - e0126939

ER -